Skip to content
DraconiticResearch
Search Sources API
197,787 studies31 sourcesUpdated 10 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

HBOCpred: An Ensemble Framework for Prioritisation of Germline Missense Variants in Hereditary Breast and Ovarian Cancer

  1. 1Department of Medical Genetics, Ankara Etlik City Hospital, 06170 Ankara, Türkiye

Abstract

HBOCpred was developed to support research prioritisation of unresolved germline missense variants in a defined 17-gene study panel. Four calibrated learners provide vote states (V0–V4) and a continuous modified adaptive classifier score (SMAC). The same directional descriptors apply to labelled and unresolved records: unanimous benign/likely benign-directed (V0), mixed (V1–V3), and unanimous likely pathogenic/pathogenic-directed (V4) votes. Development used 2160 anchors and five repeats of nested five-fold cross-validation, with preprocessing fitted within training partitions. The annotation-completeness rule permitted evaluation of 2046 anchors per repeat. Mean balanced accuracy for the secondary ≥3-of-4 endpoint was 0.9604; mean SMAC area under the receiver operating characteristic curve (AUROC) and Brier score were 0.9909 and 0.0294. In the first repeat, unanimity covered 1968/2160 anchors (91.11%), with source-label agreement in 1920/1968 unanimous outputs (97.56%). Leave-one-gene-out AUROC was 0.9812 among 2045 evaluable anchors, with substantial gene-specific variation. Among 43,679 unresolved records, V0, V1–V3, and V4 contained 33,414, 4491 and 5774 variants, respectively. HBOCpred makes learner agreement and disagreement available for expert review and functional follow-up. Independent validation is needed to assess its performance and utility in unresolved variants.

Related

  1. Benchmarking ensemble and deep learning models for drought-responsive gene prioritisation in rice using multi-omics data
    Kumanan N. Govaichelvan, Dharini Pathmanathan, Rabiatul Adawiah Zainal-Abidin +1
    PLOS OnePeer-reviewedCC BY 4.0Full textBioinformatics & computational biologyGenetics & genomicsPLOS
  2. paRDal: bioinformatics framework for a parallel RNA and DNA NGS analysis in hereditary cancer diagnostics
    Katerina Matejkova, Petr Nehasil, Petra Kleiblova +10
    Frontiers in bioinformaticsPeer-reviewedCC BYFull textGenetics & genomicsEurope PMCPMC
  3. Understanding and translating evolutionary adaptations in animals exposed to contaminated diets to guide strategies against human foodborne disease: a prioritisation framework
    Muhammad Abaidullah, Yuan Ji, Qinmiao Huang +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMCEurope PMCPMC
  4. SeverYX: An ensemble framework for robust variant severity classification
    E. Mor, E. Dedic, Y. Mazor +3
    bioRxivPreprintAll rights reservedFull textGenetics & genomicsbioRxiv
  5. An ensemble framework for robust drug response prediction and large-scale sensitivity profiling across cancers
    Yuanlong Feng, Shiling Zhou, Shengnan Luo +8
    Communications BiologyPeer-reviewedCC BY-NC-ND 4.0Full textGeneral biologyCrossref
BibTeX
@article{alay2026hbocpred,
  title = {{HBOCpred: An Ensemble Framework for Prioritisation of Germline Missense Variants in Hereditary Breast and Ovarian Cancer}},
  author = {Mustafa Tarık Alay and Haktan Bağış Erdem},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = oct,
  doi = {10.3390/ijms27198865},
  url = {https://www.mdpi.com/1422-0067/27/19/8865},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - HBOCpred: An Ensemble Framework for Prioritisation of Germline Missense Variants in Hereditary Breast and Ovarian Cancer
AU  - Mustafa Tarık Alay
AU  - Haktan Bağış Erdem
PY  - 2026
DA  - 2026/10/05
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms27198865
UR  - https://www.mdpi.com/1422-0067/27/19/8865
AB  - HBOCpred was developed to support research prioritisation of unresolved germline missense variants in a defined 17-gene study panel. Four calibrated learners provide vote states (V0–V4) and a continuous modified adaptive classifier score (SMAC). The same directional descriptors apply to labelled and unresolved records: unanimous benign/likely benign-directed (V0), mixed (V1–V3), and unanimous likely pathogenic/pathogenic-directed (V4) votes. Development used 2160 anchors and five repeats of nested five-fold cross-validation, with preprocessing fitted within training partitions. The annotation-completeness rule permitted evaluation of 2046 anchors per repeat. Mean balanced accuracy for the secondary ≥3-of-4 endpoint was 0.9604; mean SMAC area under the receiver operating characteristic curve (AUROC) and Brier score were 0.9909 and 0.0294. In the first repeat, unanimity covered 1968/2160 anchors (91.11%), with source-label agreement in 1920/1968 unanimous outputs (97.56%). Leave-one-gene-out AUROC was 0.9812 among 2045 evaluable anchors, with substantial gene-specific variation. Among 43,679 unresolved records, V0, V1–V3, and V4 contained 33,414, 4491 and 5774 variants, respectively. HBOCpred makes learner agreement and disagreement available for expert review and functional follow-up. Independent validation is needed to assess its performance and utility in unresolved variants.
SN  - 1422-0067
ER  -